封面
市场调查报告书
商品编码
1877504

2025年人工智慧(AI)增强型神经復健外骨骼市场报告

Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,人工智慧(AI)增强型神经復健外骨骼的市场规模迅速扩张,预计将从2024年的10.4亿美元成长到2025年的12.4亿美元,复合年增长率(CAGR)为18.7%。过去几年的成长可归因于復健机器人的日益普及、对提高患者活动能力的需求不断增长、科技公司与医疗公司之间合作的日益密切、医疗设备互通性的提高以及对微创復健解决方案需求的增长。

预计未来几年,人工智慧(AI)增强型神经復健外骨骼市场将快速成长,到2029年市场规模将达到24.3亿美元,复合年增长率(CAGR)为18.4%。预测期内的成长要素包括:医疗机器人投资的增加、外骨骼客製化以满足不同患者的需求、復健治疗中多学科方法的采用、发展中国家对移动解决方案的需求不断增长,以及患者对非侵入性治疗方法的偏好日益增强。预测期内的关键趋势包括:人工智慧驱动的外骨骼控制技术的进步、用于精确运动的先进感测器的整合、轻量化外骨骼设计的创新、云端基础的復健数据的应用以及个人化治疗流程的进步。

预计未来几年,神经系统疾病发生率的上升将推动人工智慧(AI)增强型神经復健外骨骼市场的成长。神经系统疾病是指影响大脑、脊髓和神经的病理状况,会导致运动、认知、感觉和其他身体功能受损。全球神经系统疾病发生率的上升主要是由于人口老化。老年人更容易患中风、失智症和帕金森氏症等疾病,这些疾病的发生率往往随着老龄化的增长而增加。人工智慧(AI)增强型神经復健外骨骼透过提供个人化、适应性的治疗来帮助神经系统疾病患者,透过即时监测和智慧调整,满足每位患者的特定需求,从而改善运动功能、促进復健并补偿运动障碍。例如,根据阿兹海默症美国的数据,大约有670万65岁及以上的美国患有老年痴呆症失智症,预计到2060年这一数字将达到1,380万。因此,神经系统疾病的日益增加正在推动人工智慧(AI)增强型神经復健外骨骼市场的成长。

人工智慧(AI)增强型神经復健外骨骼市场的主要企业正致力于整合创新技术,例如机器人控制系统,以改善患者的活动能力、稳定性以及復原效果。机器人控制系统协调管理机器人及外骨骼的运动,实现精准、稳定且适应性强的运动,帮助使用者安全且有效率地行走、站立并进行日常生活活动。例如,总部位于法国的机器人公司Wandercraft SAS于2025年5月在美国启动了一项人工智慧赋能型个人外骨骼的临床试验。该设备将先进的实体人工智慧与机器人控制系统结合,帮助脊髓损伤、中风及其他行动障碍患者安全地站立、行走并在各种地形上移动。透过即时持续适应使用者的动作,该设备能够显着改善患者的活动能力、稳定性以及復健效果。此外骨骼配备了操纵桿控制系统和智慧演算法,可预测重量、地形和速度的变化,从而增强独立性,同时最大限度地减少与长期使用轮椅相关的次要健康风险。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税,以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球人工智慧(AI)增强型神经復健外骨骼市场:PESTEL分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 终端用户产业分析
  • 全球人工智慧(AI)增强型神经復健外骨骼市场:成长率分析
  • 全球人工智慧(AI)增强型神经復健外骨骼市场表现:规模与成长,2019-2024年
  • 全球人工智慧(AI)增强型神经復健外骨骼市场预测:规模与成长,2024-2029年,2034年预测
  • 全球人工智慧(AI)增强型神经復健外骨骼市场:潜在市场规模(TAM)

第六章 市场细分

  • 全球人工智慧(AI)增强型神经復健外骨骼市场:按组件划分,实际值和预测值,2019-2024年、2024-2029年预测值、2034年预测值
  • 硬体
  • 软体
  • 服务
  • 全球人工智慧(AI)增强型神经復健外骨骼市场依移动类型划分,实际数据及预测,2019-2024年、2024-2029年预测值、2034年预测值
  • 移动的
  • 固定类型
  • 全球人工智慧(AI)增强型神经復健外骨骼市场:依技术、效能和预测划分,2019-2024年、2024-2029年预测、2034年预测
  • 电的
  • 被动的
  • 杂交种
  • 全球人工智慧(AI)增强型神经復健外骨骼市场:按应用、效能和预测划分,2019-2024年、2024-2029年预测、2034年预测
  • 中风復健
  • 脊髓损伤
  • 创伤性脑损伤
  • 多发性硬化症
  • 全球人工智慧(AI)增强型神经復健外骨骼市场:依最终用户划分,实际值和预测值,2019-2024年、2024-2029年预测值、2034年预测值
  • 医院和诊所
  • 復健中心
  • 居家照护环境
  • 全球人工智慧(AI)增强型神经復健外骨骼市场:按硬体、类型、效能和预测进行细分,2019-2024年、2024-2029年预测、2034年预测
  • 外骨骼框架
  • 致动器和电机
  • 感测器和穿戴式装置
  • 控制单元和嵌入式电子设备
  • 全球人工智慧(AI)增强型神经復健外骨骼市场:按软体、类型、效能和预测细分,2019-2024年、2024-2029年预测、2034年预测
  • 运动规划软体
  • 復健通讯协定软体
  • 数据分析与监控软体
  • 连接和整合软体
  • 全球人工智慧(AI)增强型神经復健外骨骼市场:按服务、类型、表现和预测进行细分,2019-2024年、2024-2029年预测、2034年预测
  • 安装和设定服务
  • 培训和教育服务
  • 维护和支援服务
  • 远端监控和协助服务

第七章 区域和国家分析

  • 全球人工智慧(AI)增强型神经復健外骨骼市场:区域分析、预测与趋势,2019-2024年、2024-2029年预测、2034年预测
  • 全球人工智慧(AI)增强型神经復健外骨骼市场:国家/地区、表现与预测,2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章:中国市场

第十章 印度市场

第十一章 日本市场

第十二章:澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章:西欧市场

第十六章英国市场

第十七章:德国市场

第十八章:法国市场

第十九章:义大利市场

第二十章:西班牙市场

第21章 东欧市场

第22章:俄罗斯市场

第23章 北美市场

第24章美国市场

第25章:加拿大市场

第26章 南美洲市场

第27章:巴西市场

第28章 中东市场

第29章:非洲市场

第三十章:竞争格局与公司概况

  • 人工智慧(AI)增强型神经復健外骨骼市场:竞争格局
  • 人工智慧(AI)增强型神经復健外骨骼市场:公司概况
    • Ottobock SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Shanghai Fourier Intelligence Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Kinova Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Cyberdyne Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Hocoma AG Overview, Products and Services, Strategy and Financial Analysis

第31章:其他领先和创新企业

  • Myomo Inc.
  • Neofect Co. Ltd.
  • Ekso Bionics Holdings Inc.
  • ReWalk Robotics Ltd.
  • AlterG Inc.
  • RENU ROBOTICS CORPORATION
  • ExoAtlet Global SA
  • REEV Robotics
  • Bionik Laboratories Corp.
  • Rex Bionics PLC
  • Wearable Robotics Srl
  • Gogoa Mobility Robots SL
  • Technaid SL
  • Bionic Yantra Pvt. Ltd.
  • MediTouch Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章:高潜力市场国家、细分市场与策略

  • 2029年人工智慧(AI)增强型神经復健外骨骼市场:提供新机会的国家
  • 2029年人工智慧(AI)增强型神经復健外骨骼市场:提供新机会的细分市场
  • 2029年人工智慧(AI)增强型神经復健外骨骼市场:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r39089

An AI-enhanced neurorehabilitation exoskeleton is a wearable robotic system designed to support and optimize motor recovery through intelligent, adaptive control. By leveraging advanced AI algorithms, the system continuously analyzes the user's movement patterns to provide personalized and precise assistance during therapy sessions. Through real-time feedback and dynamic adjustments, it facilitates efficient rehabilitation by improving coordination, muscle strength, and overall functional mobility over time.

The key components of artificial intelligence (AI)-enhanced neurorehabilitation exoskeletons include hardware, software, and services. Hardware encompasses the physical elements of the exoskeleton that enable safe, effective, and user-responsive assisted movement. These devices can be classified based on mobility type as either mobile or stationary and integrate various technologies, such as powered, passive, or hybrid systems. They are applied across multiple therapeutic domains, including stroke rehabilitation, spinal cord injury, traumatic brain injury, and multiple sclerosis. The main end-users of these exoskeletons include hospitals and clinics, rehabilitation centers, and home care settings, where they enhance recovery outcomes and promote patient independence.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market statistics, including artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry global market size, regional shares, competitors with the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market share, artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market segments, market trends, and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton industry. This artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market size has grown rapidly in recent years. It will grow from $1.04 billion in 2024 to $1.24 billion in 2025 at a compound annual growth rate (CAGR) of 18.7%. The growth during the historic period can be attributed to the growing adoption of rehabilitation robotics, the rising need for enhanced patient mobility, the expansion of collaborations between technology and healthcare companies, the improvement in medical device interoperability, and the increasing demand for minimally invasive rehabilitation solutions.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market size is expected to see rapid growth in the next few years. It will grow to $2.43 billion in 2029 at a compound annual growth rate (CAGR) of 18.4%. The growth during the forecast period can be attributed to increased investment in medical robotics, greater customization of exoskeleton devices to meet diverse patient needs, the adoption of interdisciplinary approaches in rehabilitation therapies, growing demand for mobility solutions in developing regions, and a rise in patient preference for non-invasive treatment options. Key trends in the forecast period include progress in AI-driven exoskeleton control, integration of advanced sensors for precise movement, innovation in lightweight exoskeleton design, incorporation of cloud-based rehabilitation data, and advancements in personalized therapy algorithms.

The rising incidence of neurological disorders is expected to drive the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market in the coming years. Neurological disorders are medical conditions that affect the brain, spinal cord, and nerves, leading to impairments in movement, cognition, sensation, or other bodily functions. The global increase in neurological disorders is largely attributed to an aging population, as older adults are more susceptible to conditions such as stroke, dementia, and Parkinson's disease, which tend to become more prevalent with age. Artificial intelligence (AI) enhanced neurorehabilitation exoskeletons assist individuals with neurological disorders by providing personalized, adaptive therapy that improves motor function, accelerates recovery, and compensates for movement impairments through real-time monitoring and intelligent adjustments to each patient's specific needs. For example, in March 2023, according to the Alzheimer's Association, a US-based nonprofit health organization, approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, and this number is projected to reach 13.8 million by 2060. Hence, the increasing incidence of neurological disorders is fueling the growth of the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market.

Major players in the artificial intelligence (AI) enhanced neurorehabilitation exoskeleton market are emphasizing the integration of innovative technologies such as robotic control systems to enhance mobility, stability, and rehabilitation outcomes. Robotic control systems are technologies that coordinate and manage the movements of a robot or exoskeleton, helping users walk, stand, and perform daily activities safely and efficiently by enabling precise, stable, and adaptive motion. For instance, in May 2025, Wandercraft SAS, a France-based robotics company, initiated clinical trials in the United States for its AI-powered personal exoskeleton. The device integrates advanced physical AI and robotic control systems to assist individuals with spinal cord injuries, stroke, and other mobility impairments in standing, walking, and navigating various surfaces safely. Continuously adapting to user movements in real time, it improves mobility, stability, and rehabilitation outcomes. Equipped with a joystick-based control system and intelligent algorithms that anticipate changes in weight, surface, and speed, the exoskeleton promotes greater independence while minimizing secondary health risks associated with long-term wheelchair use.

In July 2025, Moody Neurorehabilitation Institute Inc., a US-based healthcare organization, acquired Wandercraft SAS's Atalante X exoskeleton for an undisclosed amount. Through this acquisition, Moody Neurorehabilitation Institute Inc. aims to strengthen its rehabilitation capabilities by offering high-intensity, hands-free gait therapy, improving outcomes for patients with complex mobility challenges, including those recovering from traumatic brain injuries. Wandercraft SAS is a France-based medical robotics company that specializes in providing AI enhanced neurorehabilitation exoskeletons.

Major players in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market are Ottobock SE & Co. KGaA, Shanghai Fourier Intelligence Co. Ltd., Kinova Inc., Cyberdyne Inc., Hocoma AG, Myomo Inc., Neofect Co. Ltd., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., AlterG Inc., RENU ROBOTICS CORPORATION, ExoAtlet Global S.A., REEV Robotics, Bionik Laboratories Corp., Rex Bionics PLC, Wearable Robotics Srl, Gogoa Mobility Robots S.L., Technaid S.L., Bionic Yantra Pvt. Ltd., and MediTouch Inc.

North America was the largest region in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market in 2024. The regions covered in artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market consists of revenues earned by entities by providing services such as patient assessment services, therapy planning services, remote monitoring services, maintenance and support services, and rehabilitation consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market also includes sales of brain-computer interface (BCI)-controlled exoskeletons, occupational exoskeletons for healthcare workers, AI-integrated exoskeletons with advanced sensors, and modular and customizable exoskeleton systems. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Hardware; Software; Services
  • 2) By Mobility Type: Mobile; Stationary
  • 3) By Technology: Powered; Passive; Hybrid
  • 4) By Application: Stroke Rehabilitation; Spinal Cord Injury; Traumatic Brain Injury; Multiple Sclerosis
  • 5) By End-User: Hospitals And Clinics; Rehabilitation Centers; Home Care Settings
  • Subsegments:
  • 1) By Hardware: Exoskeleton Frames; Actuators And Motors; Sensors And Wearable Devices; Control Units And Embedded Electronics
  • 2) By Software: Motion Planning Software; Rehabilitation Protocol Software; Data Analytics And Monitoring Software; Connectivity And Integration Software
  • 3) By Services: Implementation And Setup Services; Training And Education Services; Maintenance And Support Services; Remote Monitoring And Assistance Services
  • Companies Mentioned: Ottobock SE & Co. KGaA; Shanghai Fourier Intelligence Co. Ltd.; Kinova Inc.; Cyberdyne Inc.; Hocoma AG; Myomo Inc.; Neofect Co. Ltd.; Ekso Bionics Holdings Inc.; ReWalk Robotics Ltd.; AlterG Inc.; RENU ROBOTICS CORPORATION; ExoAtlet Global S.A.; REEV Robotics; Bionik Laboratories Corp.; Rex Bionics PLC; Wearable Robotics Srl; Gogoa Mobility Robots S.L.; Technaid S.L.; Bionic Yantra Pvt. Ltd.; MediTouch Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Characteristics

3. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Trends And Strategies

4. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Growth Rate Analysis
  • 5.4. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Total Addressable Market (TAM)

6. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Segmentation

  • 6.1. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hardware
  • Software
  • Services
  • 6.2. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mobile
  • Stationary
  • 6.3. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Powered
  • Passive
  • Hybrid
  • 6.4. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stroke Rehabilitation
  • Spinal Cord Injury
  • Traumatic Brain Injury
  • Multiple Sclerosis
  • 6.5. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Rehabilitation Centers
  • Home Care Settings
  • 6.6. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Exoskeleton Frames
  • Actuators And Motors
  • Sensors And Wearable Devices
  • Control Units And Embedded Electronics
  • 6.7. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Motion Planning Software
  • Rehabilitation Protocol Software
  • Data Analytics And Monitoring Software
  • Connectivity And Integration Software
  • 6.8. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implementation And Setup Services
  • Training And Education Services
  • Maintenance And Support Services
  • Remote Monitoring And Assistance Services

7. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 8.1. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 9.1. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 9.2. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 10.1. India Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 11.1. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 11.2. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 12.1. Australia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 13.1. Indonesia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 14.1. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 14.2. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 15.1. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 15.2. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 16.1. UK Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 17.1. Germany Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 18.1. France Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 19.1. Italy Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 20.1. Spain Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 21.1. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 21.2. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 22.1. Russia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 23.1. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 23.2. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 24.1. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 24.2. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 25.1. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 25.2. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 26.1. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 26.2. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 27.1. Brazil Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 28.1. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 28.2. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

  • 29.1. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Overview
  • 29.2. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Mobility Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Competitive Landscape
  • 30.2. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Company Profiles
    • 30.2.1. Ottobock SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Shanghai Fourier Intelligence Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Kinova Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Cyberdyne Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hocoma AG Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Other Major And Innovative Companies

  • 31.1. Myomo Inc.
  • 31.2. Neofect Co. Ltd.
  • 31.3. Ekso Bionics Holdings Inc.
  • 31.4. ReWalk Robotics Ltd.
  • 31.5. AlterG Inc.
  • 31.6. RENU ROBOTICS CORPORATION
  • 31.7. ExoAtlet Global S.A.
  • 31.8. REEV Robotics
  • 31.9. Bionik Laboratories Corp.
  • 31.10. Rex Bionics PLC
  • 31.11. Wearable Robotics Srl
  • 31.12. Gogoa Mobility Robots S.L.
  • 31.13. Technaid S.L.
  • 31.14. Bionic Yantra Pvt. Ltd.
  • 31.15. MediTouch Inc.

32. Global Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

34. Recent Developments In The Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market

35. Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer